Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Por um escritor misterioso
Descrição
The Neurotoxicity of Tissue Plasminogen Activator? - Jaspreet Kaur, Zonghang Zhao, Gary M. Klein, Eng H. Lo, Alastair M. Buchan, 2004
%20market-figure-1.png)
Acute Ischemic Stroke (AIS) Market Size and Forecast to 2030
Thrombolysis in Stroke Mimics Is Not Harmless - ACEP Now
Tissue plasminogen activator (tPA): How does it treat a stroke?
NeuroEMCrit - Time is Brain - Acute Ischemic Stroke Part I: Vascular Syndromes and Thrombolysis
Thrombolysis for acute ischaemic stroke: current status and future perspectives - The Lancet Neurology
Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
NeuroEMCrit - Time is Brain - Acute Ischemic Stroke Part I: Vascular Syndromes and Thrombolysis
Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke
PDF) Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group
Alteplase for Acute Ischemic Stroke - Pharmacy & Acute Care University
de
por adulto (o preço varia de acordo com o tamanho do grupo)
